Description
Description
Flat-shaped tablets with a risk, white color. Marbling of the surface is allowed.
Packaging
60 pcs
Indications
Diseases of the central nervous system, accompanied by a decrease in intellectual-mnestic functions. As part of complex therapy: cerebrovascular insufficiency (cerebral arteriosclerosis, recovery period after ischemic and hemorrhagic stroke) encephalopathy post-toxic or post-traumatic depression psycho-organic syndrome with a predominance of signs of asthenia and adynamia vestibular disorders Meniere’s syndrome intellectual developmental lag in children prevention of migraine prevention of kinetosis in adults and children.
Contraindications
Hypersensitivity to the main and / or auxiliary components of the drug severe hepatic impairment severe renal impairment (creatinine clearance less than 20 ml / min) hemorrhagic stroke parkinsonism (including Parkinson’s disease) psychomotor agitation lactation period infantile infant age 5 years lactose intolerance, lactase deficiency, glucose-galactose malabsorption syndrome (the drug contains lactose). With caution Diseases of the liver and / or kidneys, chronic renal failure (creatinine clearance 20-80 ml / min), increased intraocular pressure of porphyria, hemostatic disorder extensive surgery, severe bleeding, hyperthyroidism, epilepsy, pronounced atherosclerosis of the cerebral vessels, tendency to neurotic reactions.
Use during pregnancy and lactation
The drug is contraindicated in pregnancy and lactation (breastfeeding).
Special instructions
From the central and peripheral nervous system: motor disinhibition, irritability, drowsiness, depression, asthenia, headache. In isolated cases, dizziness, ataxia, exacerbation of epilepsy, extrapyramidal disorders, tremor, imbalance, decreased ability to concentrate, insomnia, agitation, anxiety, hallucinations, increased sexuality are noted. From the cardiovascular system: decrease or increase in blood pressure. From the digestive system: dyspeptic phenomena, dry mouth in isolated cases – nausea, vomiting, diarrhea, abdominal pain, cholestatic jaundice. From the skin: in isolated cases, dermatitis, itching, skin rash. From the side of metabolism: weight gain. Allergic reactions: angioedema. Other: increased sweating in isolated cases – lupus-like syndrome, lichen planus.
Composition
Active ingredients: piracetam 400 mg cinnarizine 25 mg excipients: lactose monohydrate 23.5 mg magnesium hydroxycarbonate pentahydrate 46.8 mg povidone (collidone 30) 3.9 mg silicon colloidal dioxide (Aerosil A-380) 5.2 mg, calcium stearate monohydrate 5, 2 mg crospovidone (Collidone CL-M) 10.4 mg.
Dosage and Administration
Inside, during or after a meal. Adults: 1-2 tablets 3 times a day for 1-3 months, depending on the severity of the disease. It is possible to conduct repeated courses of treatment – 2-3 times a year. Children over 5 years: 1-2 tablets 1-2 times a day. Do not use for more than 3 months. For the prevention of kinetosis: in adults – 1 tablet, in children over 5 years old – 1/2 tablet 30 minutes before the start of the trip, with a second dose (if necessary) every 6-8 hours. Patients with impaired renal function: in case of chronic renal failure (creatinine clearance 20-80 ml / min) – 1 tablet 2 times a day.
Side effects
From the central and peripheral nervous system: motor disinhibition, irritability, drowsiness, depression, asthenia, headache. In isolated cases, dizziness, ataxia, exacerbation of epilepsy, extrapyramidal disorders, tremor, imbalance, decreased ability to concentrate, insomnia, agitation, anxiety, hallucinations, increased sexuality are noted. From the cardiovascular system: decrease or increase in blood pressure. From the digestive system: dyspeptic symptoms, a feeling of dry mouth in isolated cases – nausea, vomiting, diarrhea, abdominal pain, cholestatic jaundice. From the skin: in isolated cases, dermatitis, itching, skin rash. From the side of metabolism: weight gain. Allergic reactions: angioedema. Other: increased sweating in isolated cases – lupus-like syndrome, lichen planus.
Storage conditions
In a dry, dark place at a temperature of no higher than 25 ° C.
The Expiration of
is 3 years. Do not use after the expiry date, specified on the package.
Deystvuyuschee substances
Piracetam, cinnarizine
Conditions of supply of
Pharmacy Prescription
Dosage form
tablet
